Page last updated: 2024-10-27

glafenine and Hemolytic-Uremic Syndrome

glafenine has been researched along with Hemolytic-Uremic Syndrome in 1 studies

Glafenine: An anthranilic acid derivative with analgesic properties used for the relief of all types of pain.
glafenine : A carboxylic ester that is 2,3-dihydroxypropyl anthranilate in which the amino group is substituted by a 7-chloroquinolin-4-yl group. A non-steroidal anti-inflammatory drug, glafenine and its hydrochloride salt were used for the relief of all types of pain, but high incidence of anaphylactic reactions resulted in their withdrawal from the market.

Hemolytic-Uremic Syndrome: A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roodnat, JI1
Kauffmann, RH1
Gerrits, WB1
van Zijl, AM1

Other Studies

1 other study available for glafenine and Hemolytic-Uremic Syndrome

ArticleYear
[Glaphenine-induced intravascular hemolysis with acute kidney insufficiency as a consequence of IgG anti-glaphenine antibodies].
    Nederlands tijdschrift voor geneeskunde, 1987, Dec-12, Volume: 131, Issue:50

    Topics: Acute Disease; Aged; Female; Glafenine; Hemolytic-Uremic Syndrome; Humans; Immunoglobulin G; ortho-A

1987